[12] reported that PRMT5‐mediated methylation suppressed the autophosphorylation and kinase activity of the Hippo pathway initiator MST2, leading to inactivation of the Hippo signaling axis and promoting progression in pancreatic cancer. This evidence concerns the gene PRMT5 and familial pancreatic carcinoma.